Searchable abstracts of presentations at key conferences in endocrinology

ea0049gp107 | Diabetes therapy & complications 2 | ECE2017

Specific Oct1 gene variants are associated with changes in the risk of cardiovascular death in metformin users

Schweighofer Natascha , Genser Bernd , Marz Winfried , Kleber Marcus E , Pieber Thomas R , Obermayer-Pietsch Barbara

Aim: Increased cardiovascular incidents and a high risk for microvascular complications are associated with type 2 diabetes. Worldwide, metformin is the most commonly prescribed antidiabetic drug. Polymorphisms in the Oct1 gene can alter the function or activity of organic cation transporter 1 (Oct1), thus changing metformin efficacy (Oct1 acting as its main transporter) as well as influencing the actions of Oct1 physiological substrates. In the past, polymorphisms in...